The Readout Loud
STAT
STAT’s weekly biotech podcast, breaking down the latest news, digging deep into industry goings-on, and giving you a preview of the week to come.
Episodes
Mentioned books
Apr 25, 2019 • 22min
Episode 59: When scientists get mad online, for-profit cancer care, & the perils of naming a startup
Who gets to be "influential"? Should you be skeptical of for-profit hospitals? And should George Lucas fire his attorneys?
Apr 18, 2019 • 22min
Episode 58: Democratizing CRISPR, drugging the undruggable, and reading pharma's fine print
Who gets to "play God"? Can old technologies learn new tricks? And what does "drug price" even mean?
Apr 11, 2019 • 25min
Episode 57: Trump’s drug pricing foot soldier, Gilead’s uncertain future, & transpacific angst
How do you sell lefty ideas to righty politicians? What’s going on at Gilead Sciences? And why are biotech investors freaking out?
Apr 4, 2019 • 29min
Episode 56: Cheaper insulin, the next Juul, and diagnosing disease with sound
What if pharma just charged less for drugs? Can speaking three syllables reveal whether you're depressed? And why is Snoop Dogg selling erectile dysfunction pills on TV?
Mar 28, 2019 • 27min
Episode 55: The fate of Bristol-Myers-Celgene, the tragedy of SIDS, and health tech's challenges
Why can't investors think for themselves? How do parents cope with inexplicable tragedy? And is tech prepared for the toughest parts of health care?
Mar 21, 2019 • 31min
Episode 54: Another big Alzheimer’s failure, postpartum progress, and Long Island shores
Should Alzheimer's researchers just give up on amyloid plaques? What will a new drug mean for new moms with postpartum depression? And which coastal region of Long Island is superior?
Mar 14, 2019 • 32min
Episode 53: How startups stop, the new FDA boss, and Theranos on the big screen
Who deserves credit for a new gene therapy? How do you push stop on a startup? And what does MC Hammer have to do with Theranos?
Mar 7, 2019 • 28min
Episode 52: Every conceivable angle of Scott Gottlieb's FDA resignation
Why is Scott Gottlieb quitting the FDA? Who will replace him? And what's the proper elastane content of a skinny jean?
Feb 28, 2019 • 26min
Episode 51: CEOs at the Senate, merger mania, and sleuthing startups
Is this the age of the big biotech buyout? Is cold brew a business expense? And how do you pronounce "Gonzalez"?
Feb 22, 2019 • 13min
Episode 50: A big scoop on opioid marketing
What did an opioid patriarch say under oath? Why did everyone want to know so badly? And how might it shape the conversation around the opioid crisis?
